Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Hematology-Oncology

Malignant Mesothelioma Conference 2012

Latest Advancements in Mesothelioma

Lee Krug, MD, discusses the current state of mesothelioma treatments as well as new therapies in development. He mentions the possibilities of clinical trials for angiogenesis inhibitors and anti-VEGF antibodies for mesothelioma within the next 1 to 2...
A new study in Nature Biotechnology describes the importance of biomarkers in the clinical management of complex diseases as well as the limitations faced in the discovery process. While “[the] ability to discover new biomarkers remains limited by the...

Malignant Mesothelioma Conference 2012

Potential New Treatments for Mesothelioma

Mary Hesdorffer, NP and Executive Director of the Mesothelioma Applied Research Foundation, discusses the latest advances in treatment options for mesothelioma. Results from early-stage clinical trials show a future of promising treatments, including the...